Isla mint application. "Isla-moos" and "Isla-mint": instructions, application, reviews
Hello to all review readers.
I will not dwell on the reason for writing this review, I will only say that I personally would like you to know about such records for your neck. After all, these lollipops are necessary not only for those who have problems with the throat, but also for those who, due to their occupation, have a dry or sore throat.
PRICE and QUANTITY.
I bought it at a pharmacy near the clinic, you know, it’s more expensive there. It cost me 37.50 UAH. (150 rubles). Today at "LOW PRICE PHARMACY" purchased for 35.70 UAH (142.80 rubles). Not much cheaper, but still. Quantity per package: 30 pieces. That's quite a lot. I took it earlier "Doctor Mom"- it contains 16 records for 14 UAH (56 rubles). Of course, Isla Mint is not cheap, but I decided to try it anyway.
COMPOUND.
1 lozenge contains 100 mg of aqueous extract of Icelandic moss. Excipients include: sorbitol (a sugar substitute, widely known for use in liver cleansing), aspartame (another sweetener) and dye. It is also said that 1 lozenge contains 0.385 carbohydrates, which is equal to 0.03 bread unit. To be honest, I don’t understand why this is said.
PROPERTIES.
There are another lozenges called ISLA moos. I thought it was the same thing, but they have a different composition of the active substance. In Isla Mint it is larger and, accordingly, its effect is more quickly visible.
INDICATIONS.
As I said, they are used for various diseases, in my case it was LARYNGITIS, but they are also recommended for people who constantly talk and their connections are constantly working. These are teachers, and teachers, and singers, and announcers, and so on and so forth.
CONTRAINDICATIONS AND SIDE EFFECTS.
The therapist prescribed them to me when I received a side effect from Bioparox and I think she would not have advised me on lozenges that could provoke other side effects. You understand, I couldn’t stand two hives.
Contraindications are based on the fact that the composition contains a lot of sweeteners. And aspartame in large doses can cause allergies, but this is very rare. And you yourself understand that more than 5 such records a day are not recommended. Although I won’t lie, on the first day of attribution, I ate all 10 pieces. They had a very specific taste, but more on that later. And as you can see, thank God, she is alive and well and without side effects.
SPECIAL INSTRUCTIONS FOR USE.
INSTRUCTIONS.
The instructions are a huge “roll”. This tablecloth is written in two languages. On the one hand in Russian, and on the other - in Ukrainian.
FIRST IMPRESSION OF THE CANDY.
It was a wild feeling. If you compare it with other lollipops (with Doctor Mom, or at least with Travisil), then Isla mint is very specific. The lollipop itself is small, this candy is half the size of others. And in general, it’s not like a candy, it’s flexible, like rubber, I would say.
When I took it into my mouth, it was again wildly unusual that it was flexible. It stuck to my palate and the candy itself gradually melted, so to speak. The second and subsequent times I already got used to its taste and, in general, to the specifics of the candy itself.
I would also like to say that the lozenge itself is the color of moss. yes, yes, yes, it is dark green, but when it dissolves, it becomes greener and greener. :) Its shade does not change and the tongue is not stained. I think this is important to know.
I got used to them quickly and now I can’t imagine how I’ll take other lollipops. Today I bought a new package and now I will only use them and recommend them to everyone.
VERDICT: As you understand, I recommend them. Good lozenges that are worth the price. Can be taken from 4 years of age. Since there is no sugar, it can be taken by a large number of people. 5 tablets is the norm for all lollipops. Personally, I didn’t find anything scary or exciting in them. Moreover, I had no side effects from them, even at the moment when my body was weakened. Of course I recommend it for use!
Thanks everyone for stopping by! I am very pleased with your attention. Thank you for reading to the end! Be healthy!
Lozenges:
- Active ingredients: aqueous extract of Icelandic moss;
- excipients: gum arabic, sorbitol solution 70%, aspartame, peppermint oil, water-soluble chlorophyll 100% (chlorophyllin-copper complex E141), liquid paraffin, purified water.
30 lozenges weighing 1 g per package.
pharmachologic effect
Isla-Mint contains an extract from the medicinal plant Cetraria islandica (Icelandic moss), which was well known back in the days of ancient civilizations for its beneficial therapeutic effect on inflammatory diseases of the respiratory tract.
The therapeutic effect of the drug Isla-Mint for catarrhal diseases of the respiratory tract is based, first of all, on the antimicrobial activity and immunostimulating properties of the plant extract it contains, which is proven by the results of scientific research. Since Isla-Mint also has protective properties, it can also be used for prophylactic purposes, for example, in cases of special sensitivity of the respiratory tract or in case of increased stress on them (including during sports).
The polysaccharides contained in the drug envelop the mucous membranes of the airways and effectively protect them from the effects of harmful external factors and various types of irritants.
When there is a danger of a cold, the prophylactic use of the drug Isla-Mint, which can protect the mucous membranes, can reduce the susceptibility of the respiratory tract to various types of infections. The drug does not irritate the stomach.
Instructions
The Isla-Mint lozenge must be slowly dissolved in the mouth until it is completely dissolved. It is not recommended to chew the drug.
Indications for use of Isla mint
Cough, including with bronchitis; hoarseness (laryngitis, pharyngitis); BA (as an adjuvant); heavy load on the vocal cords (for singers, teachers, lecturers); dryness of the mucous membranes in the dry atmosphere of living rooms or in insufficiently humidified office spaces during the heating season, as well as with limited nasal breathing or during sports activities.
Contraindications to the use of Isla Mint
Not suitable for fructose intolerance.
Do not use Isla-Mint in patients with phenylketonuria, since the drug contains aspartame.
Isla mint Use during pregnancy and children
Isla-Mint does not have a negative effect on the fetus during pregnancy; the drug can be used during lactation.
Isla mint Side effects
There is no data on the presence of undesirable effects during the use of therapeutic doses of the drug.
Dosage of Isla mint
For the purpose of treatment in the children's age group from 4 to 12 years old - 1 lozenge with an interval of 2 hours (maximum 6 pieces per day).
Adult age group and children over 12 years old - 1 lozenge with an interval of 60 minutes (maximum 12 pieces per day).
The course of therapy is permissible for long-term use, but in a situation where there is no effect within 10 days, it is necessary to reconsider the approaches to treatment. If a therapeutic effect occurs, it is recommended to continue taking the drug for another 2-3 days in order to consolidate the effectiveness.
For the purpose of prevention, the drug may be used in doses that are used for medicinal purposes.
For prophylaxis in case of high load on the respiratory tract (sore throat in speakers, teachers, during sports activities), take 1 lozenge 3 times a day.
Manufacturer: Engelhard Arzneimittel GmbH & Co. KG
Anatomical-therapeutic-chemical classification: Preparations for the treatment of diseases of the pharynx
Registration number in the Republic of Kazakhstan: No. RK-LS-5No. 015502
Registration period: 05.11.2015 - 05.11.2020
Instructions
Tradename
Isla-Mint®
International nonproprietary name
Dosage form
Lozenges for resorption
Compound
One lozenge contains
active substance - Icelandic moss extract aqueous (2 - 4: 1) 100.00 mg, Excipients: gum arabic 85%, sorbitol solution 70% (without crystallization), sorbitol solution 70% from extract, aspartame, peppermint oil, chlorophyllin copper complex E 141, liquid paraffin, purified water.
Description
Flat, unevenly rounded, lens-shaped, green rubbery lozenges with peppermint flavor, height 4.6 mm - 0.6 mm / +1.4 mm, diameter 16.0 mm ± 0.5 mm. May contain air bubbles
Pharmacotherapeutic group
Preparations for the treatment of throat diseases
ATX code R02A
Pharmacological properties
Pharmacokinetics
Pharmacokinetic data are not described.
Pharmacodynamics
The Isla-Mint lozenge contains an extract from the medicinal plant Icelandic moss, which was well known back in the days of ancient civilizations for its beneficial therapeutic effect on inflammatory diseases of the respiratory tract.
The therapeutic effect of the drug Isla-Mint lozenges for catarrhal diseases of the respiratory tract is based primarily on the antimicrobial activity and immunostimulating effect of the plant extract it contains, which is proven by the results of scientific research. The polysaccharides contained in the preparation envelop the mucous membranes of the airways and effectively protect them from the action of harmful external factors and various irritants. Since the drug also has an enveloping effect, it can also be used for preventive purposes, for example, with special sensitivity of the respiratory tract or with increased stress on them (including during sports).
When there is a danger of a cold, the prophylactic use of the drug Isla-Mint lozenges, which can protect the mucous membranes, can reduce the susceptibility of the respiratory tract to various types of infections.
Indications for use
Inflammatory diseases of the upper respiratory tract, accompanied by dry cough, hoarseness, catarrhal bronchitis, as part of complex therapy for bronchial asthma
Dryness of the mucous membranes of the upper respiratory tract in residential and office spaces during the heating season, as well as with limited nasal breathing or during sports activities
Directions for use and doses
Adults and children over 12 years of age: Take 1 lozenge every hour (up to 12 lozenges per day), allowing them to dissolve slowly in the mouth.
Children from 4 to 12 years old: take 1 lozenge every 2 hours (up to 6 lozenges per day), allowing them to slowly dissolve in the mouth.
The course of treatment is 10 days. If after 10 days of using the drug there is no improvement, you should consult your doctor.
Due to the good tolerance of the drug, Isla-Mint lozenges can be used for a long time. In addition, even after eliminating the symptoms of the disease, Isla-Mint should be taken for another 2-3 days in order to achieve a lasting therapeutic effect.
For prophylactic purposes to protect the respiratory tract when there is an increased load on them (soreness in the throat or increased stress, for example, speech, sports), take Isla-Mint 1 lozenge several times a day, allowing it to slowly dissolve in the mouth, not exceeding this is the maximum daily dose.
Side effects
Hypersensitivity to any ingredient of the drug
Very rarely
Laxative effect, since the drug contains sorbitol
Contraindications
Hypersensitivity to any ingredient of the drug
If you have phenylketonuria, you must take into account that the drug contains the sweetener aspartame
Fructose intolerance
Children under 4 years old
Drug interactions
Not known
special instructions
Isla-Mint does not contain sugar, so it can be prescribed to patients with diabetes.
1 lozenge corresponds to 0.03 bread unit = 0.385 g of carbohydrates.
The plant extract from Icelandic moss contained in the Isla-Mint lozenges can sometimes change the color and taste of the drug, which does not affect the therapeutic effect.
Pregnancy and lactation
There is no data on the tolerability of the drug during pregnancy and lactation. If necessary, use only after consulting a doctor.
Features of the influence on the ability to drive a vehicle or potentially dangerous mechanisms
Does not affect
Overdose
Not identified
Release form and packaging
10 lozenges per blister pack made of polyvinyl chloride film and printed varnished aluminum foil.
3 contour strip packs together with instructions for medical use in the state and Russian languages are placed in a cardboard pack.
Storage conditions
Store in a dry place at a temperature not exceeding 25°C.
Keep out of the reach of children!
Shelf life
Do not use after the expiration date.
Conditions for dispensing from pharmacies
Over the counter
Manufacturer/ Packaging organization
Registration Certificate Holder
Engelhard Arzneimittel GmbH & Co. KG.
Herzbergstrasse 3, 61138 Niederdorfelden, Germany.
Address of the organization that accepts claims from consumers regarding the quality of products (products) on the territory of the Republic of Kazakhstan
Alpen Pharma LLP
Almaty, microdistrict. Zhetysu-2, 80, apt. 54
Tel./fax + 7 727 2265306 E-mail: info. [email protected]
Head of department Kuzdenbaeva R.S.
Pharmacological examination
Deputy Head Baydullaeva Sh.A.
Department
Pharmacological
examination
Expert
Applicant
Director of Alpen Pharma LLP Kim R.A.
Attached files
| 101083171477976358_ru.doc | 62.5 kb |
| 074901421477977559_kz.doc | 52 kb |
Instructions for medical use of the drug
Isla-Mint ®
Trading onhtion
Isla-Mint ®
International nonproprietary name
Dosage form
Lozenges for resorption
Compound
One lozenge contains
active substance - Icelandic moss extract aqueous (2 - 4: 1) 100.00 mg,
Excipients: gum arabic 85%, sorbitol solution 70% (without crystallization), sorbitol solution 70% from extract, aspartame, peppermint oil, chlorophyllin copper complex E 141, liquid paraffin, purified water.
Description
Flat, unevenly rounded, lens-shaped, green rubbery lozenges with peppermint flavor, height 4.6 mm - 0.6 mm / +1.4 mm, diameter 16.0 mm ± 0.5 mm. May contain air bubbles
Pharmacotherapeutic group
Preparations for the treatment of throat diseases
ATX code R02A
Pharmacological properties
Pharmacokinetics
Pharmacokinetic data are not described.
Pharmacodynamics
The Isla-Mint lozenge contains an extract from the medicinal plant Icelandic moss, which was well known back in the days of ancient civilizations for its beneficial therapeutic effect on inflammatory diseases of the respiratory tract.
The therapeutic effect of the drug Isla-Mint lozenges for catarrhal diseases of the respiratory tract is based primarily on the antimicrobial activity and immunostimulating effect of the plant extract it contains, which is proven by the results of scientific research. The polysaccharides contained in the preparation envelop the mucous membranes of the airways and effectively protect them from the action of harmful external factors and various irritants. Since the drug also has an enveloping effect, it can also be used for preventive purposes, for example, with special sensitivity of the respiratory tract or with increased stress on them (including during sports).
When there is a danger of a cold, the prophylactic use of the drug Isla-Mint lozenges, which can protect the mucous membranes, can reduce the susceptibility of the respiratory tract to various types of infections.
Indications for use
inflammatory diseases of the upper respiratory tract, accompanied by dry cough, hoarseness, catarrhal bronchitis, as part of complex therapy for bronchial asthma
dryness of the mucous membranes of the upper respiratory tract in residential and office spaces during the heating season, as well as with limited nasal breathing or during sports activities
Directions for use and doses
Adults and children over 12 years of age: Take 1 lozenge every hour (up to 12 lozenges per day), allowing them to dissolve slowly in the mouth.
Children from 4 to 12 years old: take 1 lozenge every 2 hours (up to 6 lozenges per day), allowing them to slowly dissolve in the mouth.
The course of treatment is 10 days. If after 10 days of using the drug there is no improvement, you should consult your doctor.
Due to the good tolerance of the drug, Isla-Mint lozenges can be used for a long time. In addition, even after eliminating the symptoms of the disease, Isla-Mint should be taken for another 2-3 days in order to achieve a lasting therapeutic effect.
For prophylactic purposes to protect the respiratory tract when there is an increased load on them (soreness in the throat or increased stress, for example, speech, sports), take Isla-Mint 1 lozenge several times a day, allowing it to slowly dissolve in the mouth, not exceeding this is the maximum daily dose.
Side effects
Hypersensitivity to any ingredient of the drug
Very rarely
Laxative effect, since the drug contains sorbitol
Contraindications
Hypersensitivity to any ingredient of the drug
If you have phenylketonuria, you must take into account that the drug contains the sweetener aspartame
Fructose intolerance
Children under 4 years old
Drug interactions
Not known
special instructions
Isla-Mint does not contain sugar, so it can be prescribed to patients with diabetes.
1 lozenge corresponds to 0.03 bread unit = 0.385 g of carbohydrates.
The plant extract from Icelandic moss contained in the Isla-Mint lozenges can sometimes change the color and taste of the drug, which does not affect the therapeutic effect.
Pregnancy and lactation
There is no data on the tolerability of the drug during pregnancy and lactation. If necessary, use only after consulting a doctor.
Features of the influence on the ability to drive a vehicle or potentially dangerous mechanisms
Does not affect
Overdose
Not identified
Release form and packaging
10 lozenges per blister pack made of polyvinyl chloride film and printed varnished aluminum foil.
3 contour strip packs together with instructions for medical use in the state and Russian languages are placed in a cardboard pack.
Storage conditions
Store in a dry place at a temperature not exceeding 25°C.
Keep out of the reach of children!
Shelf life
Do not use after the expiration date.
Conditions for dispensing from pharmacies
Over the counter
Manufacturer/ Packaging organization
Registration Certificate Holder
Engelhard Arzneimittel GmbH & Co. KG.
Herzbergstrasse 3, 61138 Niederdorfelden, Germany.
Address of the organization that accepts claims from consumers regarding the quality of products (products) on the territory of the Republic of Kazakhstan
Alpen Pharma LLP
Almaty, microdistrict. Zhetysu-2, 80, apt. 54
Tel./fax + 7 727 2265306 E-mail: info. [email protected]
active substance: aqueous extract of Icelandic moss;
1 lozenge contains 100 mg of aqueous extract of Iceland mos (Iceland moos) ((2-4):1); extractant: water; contains sorbitol solution (1:2);
Excipients: sorbitol solution, non-crystallizing (E 420); aspartame (E 951), gum arabic, peppermint oil, copper chlorophyll complexes (E 141), light mineral oil, purified water;
1 lozenge contains 0.385 g of carbohydrates, which corresponds to 0.03 bread units.
Dosage form. Pastilles.
Basic physical and chemical properties: flat, unevenly rounded, lens-like, green rubbery lozenges with peppermint flavor, the presence of air bubbles is allowed.
Pharmacotherapeutic group.
Medicines used for throat diseases. ATX code R02A.
Pharmacological properties
Pharmacodynamics.
The medicinal product contains an extract from a medicinal plant Cetraria islandica(Icelandic moss), which is known for its therapeutic effect in inflammatory diseases of the respiratory tract.
The therapeutic effect of the drug for catarrhal diseases of the respiratory tract is based on the antimicrobial activity and immunostimulating properties of the plant extract it contains, which has been proven by the results of scientific research. The polysaccharides contained in the drug envelop the mucous membranes of the airways and effectively protect them from the action of harmful external factors and various types of irritants. Since the drug also has protective properties, it can also be used for preventive purposes, including when playing sports.
Prophylactic use of the drug can protect mucous membranes and can reduce the susceptibility of the respiratory tract to infections. The medicine does not irritate the stomach.
Pharmacokinetics. No data available.
Clinical characteristics.
Indications
Cough, including with bronchitis; hoarseness (laryngitis, pharyngitis); bronchial asthma (as an adjuvant). Increased load on the vocal cords (singers, teachers, lecturers). Dryness of the mucous membranes due to dry air in living rooms or insufficiently humidified office spaces during the heating season, as well as with limited nasal breathing or during sports activities.
Contraindications
Hypersensitivity to the active substance or other components of the drug.
Fructose intolerance.
Interaction with other drugs and other types of interactions.
Until now it is unknown.
Features of application
If you have phenylketonuria, you must take into account that the drug contains the sweet substance aspartame (E 951).
If you have fructose intolerance, please note that the drug contains the sweet substance sorbitol (E 420).
Plant extracts contained in a medicinal product can sometimes cause deviations in the color and taste of this medicinal product, which does not in any way affect its therapeutic effect.
The drug Isla-Mint does not contain sugar, so it can be prescribed to patients suffering from diabetes.
1 lozenge corresponds to 0.03 bread units = 0.385 g of carbohydrates.
Use during pregnancy or breastfeeding.
There has been no information about the negative effects of the drug during pregnancy or breastfeeding. However, special studies have not been conducted in this category of patients, so the risk/benefit ratio should be weighed before using the drug.
The ability to influence the reaction rate when driving vehicles or other mechanisms.
If the drug is used according to these instructions, then no negative consequences of its use are expected.
Directions for use and doses
Adults and children over 12 years of age take 1 lozenge every hour (up to 12 lozenges per day), children from 4 to 12 years old take 1 lozenge every 2 hours (up to 6 lozenges per day), allowing them to slowly dissolve in the mouth.
Isla-Mint can be used for a long time.
In addition, even after the symptoms of the disease disappear, Isla-Mint should be taken for several more days in order to achieve a lasting therapeutic effect.
If persistent symptoms of the disease do not decrease within 4 to 5 days or, on the contrary, worsen, if shortness of breath, fever, as well as purulent sputum and sputum with blood occur, you should immediately consult a doctor.
Children.
The drug should be prescribed to children from 4 years of age, since the lozenges must be kept in the mouth, allowing them to slowly dissolve.
Overdose
There have been no reports of overdose.
Adverse reactions
In rare cases, allergic reactions may occur.
Very rarely, the drug may have a laxative effect in sensitive patients, as it contains sorbitol.
Best before date
Do not use after the expiration date indicated on the package.
Storage conditions
Store in original packaging at a temperature not exceeding 25 °C. Keep out of the reach of children.
Package
10 lozenges in a blister; 3 blisters in a cardboard box.
Over the counter.
Manufacturer
Engelhard Arzneimittel GmbH & Co. KG/
Engelhard Arzneimittel GmbH & Co. KG.
The location of the manufacturer and the address of the place of its activities.
Herzbergstrasse 3, 61138 Niederdorfelden, Germany/
Herzbergstrasse 3, 61138 Niederdorfelden, Germany.